Resmetirom Approval Marks a Milestone in MASH Treatment

agregó una foto Health

2025-06-17 07:37:44

Metabolic Dysfunction-Associated Steatohepatitis (MASH), previously known as Nonalcoholic Steatohepatitis (NASH), represents a progressive form of metabolic liver disease closely linked to obesity, type 2 diabetes, and insulin resistance. This reclassification under the broader Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) framework reflects a shift toward understanding liver...

0 Commentarios 0 Acciones 68 Views 0 Vista previa